Tocilizumab

Tocilizumab, a wɔtɔn no wɔ Actemra din mu, yɛ aduro na ɛboa nipadua no ma ɛko tia nyarewa, wɔde di rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID-19, ne systemic sclerosis-associated interstitial lung disease (SSc-ILD) ho dwuma. Ɛyɛ monoclonal antibody a wɔde di interleukin-6 receptor (IL-6R) so. Interleukin 6 (IL-6) yɛ cytokine bi a ɛboa kɛse wɔ nipadua mu nipadua no ho banbɔ mu, na ɛboa ma nyarewa pii te sɛ autoimmune yare, multiple myeloma ne prostate cancer ba. Osaka Sukuupɔn ne Chugai yɛɛ tocilizumab, na Hoffmann-La Roche maa no tumi krataa wɔ afe 2003 mu.